Harris Angela J, Dial Stacey L, Casciano Daniel A
Center for Hepatotoxicity, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Drive, Jefferson, AR 72079, USA.
Mutat Res. 2004 May 18;549(1-2):79-99. doi: 10.1016/j.mrfmmm.2003.11.014.
Toxicogenomics is a relatively new discipline of toxicology. Microarrays and bioinformatics tools are being used successfully to understand the effects of toxicants on in vivo and in vitro model systems, and to gain a better understanding of the relevance of in vitro models commonly used in toxicological studies. In this study, cDNA filter arrays were used to determine the basal expression patterns of human cultured primary hepatocytes from different male donors; compare the gene expression profile of HepG2 to that of primary hepatocytes; and analyze the effects of three genotoxic hepatocarcinogens; aflatoxin B(1) (AFB(1)), 2-acetylaminofluorene (2AAF), and dimethylnitrosamine (DMN), as well as one non-gentoxic hepatotoxin, acetaminophen (APAP) on gene expression in both in vitro systems. Real-time PCR was used to verify differential gene expression for selected genes. Of the approximately 31,000 genes screened, 3-6% were expressed in primary hepatocytes cultured on matrigel for 16 h. Of these genes, 867 were expressed in cultured hepatocytes from all donors. HepG2 cells expressed about 98% of the genes detectable in cultured primary hepatocytes, however, 31% of the HepG2 transcriptome was unique to the cell line. A number of these genes are expressed in human liver but expression is apparently lost during culture. There was considerable variability in the response to chemical carcinogen exposure in primary hepatocytes from different donors. The transcription factors, E2F1 and ID1 mRNA were increased three-fold and six-fold (P < 0.05, P < 0.01), respectively, in AFB(1) treated primary human hepatocytes but were not altered in HepG2. ID1 expression was also increased by dimethylnitrosamine, acetylaminofluorene and acetaminophen in both primary hepatocytes and HepG2. Identification of genes that are expressed in primary hepatocytes from most donors, as well as those genes with variable expression, will aid in understanding the variability in human reactions to drugs and chemicals. This study suggests that identification of biomarkers of exposure to some chemicals may be possible in the human through microarray analysis, despite the variability in responses.
毒理基因组学是毒理学中一门相对较新的学科。微阵列和生物信息学工具正成功用于了解毒物对体内和体外模型系统的影响,并更好地理解毒理学研究中常用的体外模型的相关性。在本研究中,cDNA滤膜阵列用于确定来自不同男性供体的人培养原代肝细胞的基础表达模式;比较HepG2与原代肝细胞的基因表达谱;并分析三种遗传毒性肝癌致癌物黄曲霉毒素B(1)(AFB(1))、2-乙酰氨基芴(2AAF)和二甲基亚硝胺(DMN)以及一种非遗传毒性肝毒素对乙酰氨基酚(APAP)在两种体外系统中对基因表达的影响。实时PCR用于验证所选基因的差异基因表达。在筛选的约31,000个基因中,3%-6%在基质胶上培养16小时的原代肝细胞中表达。在这些基因中,867个在所有供体的培养肝细胞中表达。HepG2细胞表达了培养原代肝细胞中可检测到的约98%的基因,然而,HepG2转录组的31%是该细胞系特有的。这些基因中有许多在人肝脏中表达,但在培养过程中表达明显丧失。不同供体的原代肝细胞对化学致癌物暴露的反应存在相当大的变异性。在AFB(1)处理的原代人肝细胞中,转录因子E2F1和ID1 mRNA分别增加了三倍和六倍(P<0.05,P<0.01),但在HepG2中未改变。在原代肝细胞和HepG2中,二甲基亚硝胺、乙酰氨基芴和对乙酰氨基酚也增加了ID1的表达。鉴定大多数供体原代肝细胞中表达的基因以及那些表达可变的基因,将有助于理解人类对药物和化学物质反应的变异性。这项研究表明,尽管反应存在变异性,但通过微阵列分析在人类中识别某些化学物质暴露的生物标志物可能是可行的。